How to achieve international action on falsified and substandard medicines

Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms. Amir Attaran and colleagues propose a global treaty to overcome the problems


Publication year:
2012
In:
In: BMJ : British Medical Journal. - London. - 345(2012), Issue 7884, p. 23-26
Notes:
And 3 other authors

Note: The status of this file is: restricted


 Record created 2013-01-15, last modified 2019-09-13

Fulltext:
Download fulltext
PDF

Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)